Illumina, Inc. (NASDAQ: ILMN), a pioneer in genome sequencing technology, has strived to strengthen its unique position in the healthcare sector through
Illumina (ILMN) is uniquely placed to offer long-term returns. Here’s why
Categories
Health Care
IsoRay Inc. (ISR) Q4 2020 Earnings Call Transcript
IsoRay Inc (NYSEAMERICAN : ISR) Q4 2020 earnings call dated Sep. 17, 2020 Corporate Participants: Mark Levin -- Investor Relations Lori A. Woods -- Chief Executive
Veritas Farms Inc. (VFRM) Q4 2020 Earnings Call Transcript
Veritas Farms Inc. (OTCMKTS : VFRM) Q4 2020 earnings call dated Sep. 17, 2020 Corporate Participants: Derek Thomas -- Vice President Of Business Development
Cantel Medical Corp. (NYSE: CMD) Q4 2020 Earnings Call Transcript
Cantel Medical Corp. (NYSE: CMD) Q4 2020 earnings call dated Sep. 17, 2020 Corporate Participants: Matthew C. Micowski -- Vice President, Financial Planning &
Humana (HUM) can offer long-term returns despite high valuation
https://www.youtube.com/watch?v=zOVB6xD8rS4 There has been a marked decrese in the number of people seeking healthcare services since the virus outbreak but most healthcare
COVID-19 vaccine development: A look at some of the pharma companies and their progress
The COVID-19 pandemic continues to go on and while the world is slowly coming out of the previously imposed strict lockdown, things
Silence Therapeutics PLC (SLN) Q2 2020 Earnings Call Transcript
Silence Therapeutics PLC (LON: SLN) Q2 2020 earnings call dated Sep. 14, 2020 Corporate Participants: Gem Hopkins -- Head of Investor Relations and Corporate
NovoCure (NVCR): Why this medtech firm matters
Even as COVID-19 is wreaking havoc across the world, cancer continues to kill about 10 million people per year, and the quest
NovoCure Limited (NVCR) Q2 2020 Earnings Call Transcript
NovoCure Limited (NASDAQ: NVCR) Q2 2020 earnings call dated Jul. 30, 2020 https://www.youtube.com/watch?v=f1kpNPlyXaE&t=455s Corporate Participants: Ashley Cordova -- Senior Vice President of Finance &
Avid Bioservices, Inc. (CDMO) Q1 2021 Earnings Call Transcript
Avid Bioservices, Inc. (NASDAQ: CDMO) Q1 2021 earnings call dated Sep. 01, 2020 Corporate Participants: Tim Brons -- Investor Relations Nicholas Green -- President & Chief
Aimmune Therapeutics Inc (AIMT) Q2 2020 Earnings Call Transcript
Aimmune Therapeutics Inc (NASDAQ: AIMT) Q2 2020 earnings call dated July 30, 2020 Corporate Participants: DeDe Sheel -- Vice President of Investor Relations
Medtronic (MDT) revisits business strategy even as recovery gathers steam
https://www.youtube.com/watch?v=ukh0vaOtvBw For Medtronic plc (NYSE:MDT), the last two quarters were disappointing as healthcare institutions postponed routine medial procedures and channeled their resources
Will da Vinci power help Intuitive Surgical (ISRG) beat COVID blues?
Being part of a rapidly growing industry and having a successful business model can be a winning combination in difficult times like
Medtronic PLC (MDT) Q1 2021 Earnings Call Transcript
Medtronic PLC (NYSE: MDT) Q1 2021 earnings call dated Aug. 25, 2020 Corporate Participants: Ryan Weispfenning -- Vice President, Investor Relations Geoffrey S. Martha -- Chief
Should you buy Liminal BioSciences (LMNL) stock?
So far, COVID-19 has claimed more than 800,000 lives all over the world. The biomedical community is rigorously working on finding an
Medtronic (MDT) Earnings: 1Q21 Key Numbers
Medtronic plc (NYSE:MDT) reported first quarter 2021 earnings results today. Worldwide revenue decreased 13% to $6.5 billion. GAAP net income was $487
Stable demand should help PetMed (PETS) emerge stronger from pandemic
PetMed Express (NASDAQ: PETS) has been around for a long time, expanding its foothold in the lucrative pet care market at a
Agilent Technologies Inc. (A) Q3 2020 Earnings Call Transcript
Agilent Technologies Inc (NYSE: A) Q3 2020 earnings call dated Aug. 18, 2020 Corporate Participants: Ankur Dhingra -- Vice President of Investor Relations Mike
CureVac (CVAC): Another COVID-19 stock that attracted investors
In recent times, investors have been betting on the biotech companies that are in the race to develop the COVID-19 vaccine. The
Veru Inc. (VERU) Q3 2020 Earnings Call Transcript
Veru Inc. (NASDAQ: VERU) Q3 2020 earnings call dated Aug. 13, 2020 Corporate Participants: Samuel Fisch -- Director, Investor Relations Mitchell Steiner -- Chairman, President, and
Is Altimmune (ALT) stock a buy right now?
A lot of stocks in the biotech space have skyrocketed this year after their announcements and advances in finding a vaccine or